12 Health Care Stocks Moving In Friday's Intraday Session
Oric Pharmaceuticals Inc ORIC
$11.07
▼ -4.90%
($-0.57)
🔥 High Short Interest
🗓️ Earnings Next Week
Open
$11.67
Prev Close
$11.64
Day Range
$10.98 – $11.75
52W Range
$7.23 – $14.93
Market Cap
$1.15B
Beta
0.93
EPS (TTM)
$-1.43
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-04-24 |
| Shares Out. | 103,520,000 |
| Website | oricpharma.com/ ↗ |
| Phone | 13026587581 |
| Employees | 104 |
| Net Income | -$35.8M |
| Free Cash Flow | -$111.2M |
| Total Assets | $436.8M |
| Total Liabilities | $21.2M |
| Equity | $415.6M |
About Oric Pharmaceuticals Inc
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Oric Pharmaceuticals Inc is a publicly traded company under the ticker symbol ORIC on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
22 analysts (2026-07-01)